October 14, 2021
Physician at a satellite clinical trial site

Why Satellite Sites are the Next Rising Stars in Clinical Research

With the unprecedented increase of innovative clinical trials in oncology comes a new emphasis on broadening access, resulting in trials moving closer to where patients live. These developments make the untapped potential of satellite and affiliate locations an important niche to develop. Their unused capacity and often unrecognized capabilities can […]
September 17, 2021
Questions about the future of the UK clinical trial scene

BREXIT: What has Changed in the United Kingdom Clinical Trial Regulatory Landscape?

After years in the making, Brexit has occurred, and the downstream ramifications on the clinical research industry are now starting to roll out.   If you are planning a clinical study that will enrol patients in the United Kingdom (U.K.), this article will aid your efforts and preparations. The U.K.’s departure […]
July 15, 2021

The Multistakeholder Healthcare Environment – The Evolving Role of Regulators

In this article, we discuss our observations on today’s healthcare landscape and regulation of clinical research; how it continues to evolve the role of regulators in a multistakeholder environment.
May 17, 2021

Phase 1/2 Combination Studies: Best Practices When Moving From Escalation to Expansion

In this article, we discuss best practices for combination Phase 1/2 studies and how to maintain momentum moving from escalation to expansion.
April 5, 2021

Precision for Medicine: Powered by Our People

Precision for Medicine as a global CRO, invests in our employee’s success through our comprehensive training and development ecosystem. We are Powered by Our People.
March 17, 2021
Etigilimab decreases Treg frequency

Next Generation Immune Monitoring in Immuno-oncology Trials

A critical component of I-O studies, immune monitoring is essential for understanding, predicting, and monitoring the immune system response to therapeutic interventions. Epiontis ID is a next generation method of immune monitoring based on measuring cell type-specific epigenetic markers that identify uniquely demethylated regions on genomic DNA. Learn more, and view the on demand webinar.
February 4, 2021

Taking a Holistic Approach to Sample Management and Sample Processing for Your Clinical Trial

Patient samples have always been critical assets for clinical trial success. In this era of precision medicine, in which researchers seek to tailor treatments on the basis of a specific patient’s biomarker profile or disease characteristics, sample management has become even more important and valuable. It is critical to ensure that clinical samples collected during a trial constitute a robust sample set that can be used for elucidating mechanism of action, stratifying patients, and monitoring response to treatment. Consequently, having a plan to ensure sample quality, minimize processing time post-blood draw, and manage logistics is crucial for optimizing the accuracy and integrity of clinical trial data.
February 4, 2021

Why Immuno-Oncology Slowed and How to Reignite It

Cancer immunotherapy advances continue and enthusiasm for these approaches remains high yet the pace of innovation has noticeably slowed.